Sanaz Ahmadi Ghezeldasht

8PUBLICATIONS
12CO-AUTHORS
Haematological tumoursImmunogenetics (incl. genetic immunology)Molecular medicineTissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 10, 2024
Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature.

Mohammad Reza Hedayati-Moghaddam, Farahnaz Tehranian, Arman Mosavat

|Aug 02, 2023
Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo.

Sanaz Ahmadi Ghezeldasht, Hamid Reza Bidkhori, Raheleh Miri

|Jan 03, 2023
Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL).

Sanaz Ahmadi Ghezeldasht, David J Blackbourn, Arman Mosavat

|Nov 18, 2022
Development of a Novel HTLV-1 Protease: Human Fcγ1 Recombinant Fusion Molecule in the CHO Eukaryotic Expression System.

Sanaz Ahmadi Ghezeldasht, Mastoureh Momen Heravi, Narges Valizadeh

|Mar 20, 2021
HTLV-1 oncovirus-host interactions: From entry to the manifestation of associated diseases.

Sanaz Ahmadi Ghezeldasht, Seyed Ali Akbar Shamsian, Jamshid Gholizadeh Navashenaq

Pageof 2